Navigation Links
Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis

SAN CARLOS, Calif., July 5 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO) today announced that data from the ANTHEM (Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 Phase 2 trial looking at recombinant nematode anticoagulant protein c2 (rNAPc2) in patients with acute coronary syndromes (ACS), preclinical data evaluating rNAPc2 in mouse models of colorectal cancer, and preclinical data evaluating the mechanism of NU172, a short-acting, direct thrombin inhibiting aptamer, will be presented at the XXIst Congress of the International Society on Thrombosis and Haemostasis (ISTH) taking place in Geneva, Switzerland, July 6-12, 2007.

The presentation details are as follows:
Date/Time: Sunday, July 8, 2007, 5:30 p.m. CEST
Poster Session (P-S-016): Tissue Factor/Factor VIIa Inhibitor Reduces
Ischemia in Patients with NSTE-ACS: Final Results of the ANTHEM-TIMI
32 Trial

Date/Time: Sunday, July 8, 2007, 5:30 p.m. CEST
Poster Session (P-S-067): Discovery of a Potent, Direct Thrombin
Inhibiting Aptamer

Date/Time: Sunday, July 8, 2007, 5:30 p.m. CEST
Poster Session (P-S-072): Pharmacokinetic/Pharmacodynamic Profile of a
Novel Aptamer Direct Thrombin Inhibitor in Cynomolgus Monkeys and
Yorkshire Pigs Following a Single IV Bolus Administration

Date/Time: Monday, July 9, 2007, 10:00 a.m. CEST
Oral Presentation (O-M-001): rNAPc2, a Novel Inhibitor of Tissue
Factor/Factor VIIa Complex, Synergizes with 5-FU or Bevacizumab in a
Mouse Model of Colorectal Cancer

Date/Time: Tuesday, July 10, 2007, 5:30 p.m. CEST
Poster Session (P-T-509): rNAPc2, a Novel Inhibitor of Tissue
Factor/Factor VIIa Complex, Suppresses Liver and Lung Metastases in Mouse
Models of Colorectal Cancer

About NuveloNuvelo, Inc. i
'"/>




Page: 1 2 3

Related medicine technology :

1. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
2. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
3. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
4. Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
5. Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...ire-FirstCall/ -- Smith & Nephew ( SNN, LSE: S...e signing of a technology development contract wit... lead to the creation of a fracture fixation syste...imbs of soldiers who sustain battlefield injuries....ojects Agency (DARPA), the central research and de...
(Date:11/19/2009)...wswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc...a public offering of 5,000,000 shares of its commo...ceeds of $48.75 million. All of the shares are be...helf registration statement previously filed with ...has also granted the underwriters a 30-day option ...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 1NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 2NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 3NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 4NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 5NACDS Urges Clarifications Enhancements in Two Pharmacy Reimbursement Provisions in House Healthcare Reform Legislation 52163 6American Red Cross Charged With Bio Hazardous Waste Dumping 52159 1MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 1MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 2MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 3MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 4MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 5
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-USNew... urging senators to modify health care reform legi...guage regarding a health insurance individual cove... and enforceable mandate will minimize adverse sel...ting rules prescribed by the bill. ,, "The indi...
(Date:11/20/2009)..., , QUINCY, Mass., Nov. 20 ... Supermarket Company removed from sale Shedd,s Cou...oli Rice and Shedd,s Country Crock ® Side Dis...sulfite allergen. ,, The following code dates ...k ® Side Dishes DELUXE Cheddar Broccoli Rice ...
(Date:11/20/2009)..., , MADISON, N.J., Nov. 20 /PRNewswire-F...nfluenza virus may have peaked in late October, bu...al source of illness in all age groups, including ...agnostics Incorporated (NYSE: DGX ), the world,s...on and services. ,, In its most recent Quest D...
(Date:11/20/2009)..., , ST. LOUIS, Nov. 20 /PRNewswire-First...y announced that it will present at the Bank of Am...held December 2-3, 2009, at the Crowne Plaza Hotel... present Wednesday, December 2nd at 8:30 a.m. East...ay access a live, audio webcast of Centene,s prese...
(Date:11/20/2009)..., , WINSTON-SALEM, N.C., Nov. 20 /PRNewswir...t he is on a mission to redefine what it means to ...essional counselor with a specialty in family coun...t Wake Forest University, Gladding says research s...n leads to sadness and even depression during the ...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2
...shes between,rebels and government troops have cau...ic of Congo, International Medical Corps (IMC) con...s fleeing the fighting, while,working to maintain ...ing operations to,camps further south from the fig...
...tiva Health,Services, Inc. (Nasdaq: GTIV ), a lea...s, announced today that it plans to present at Nov... & Co., Credit Suisse and,Stephens Inc., The Comp...erence in New York. -- 4:30 p.m. to 4:55 p.m. MT...
...cies and standardization to personalize patient ...Calif., Oct. 30 Roche Molecular Diagnostics,today...n (FDA) has approved,the COBAS(R) AmpliPrep / COBA... RNA in a patient,s blood. Physicians use,Hepatiti...
...eals Nanoparticles Present in 4 out of 5,Sunscreen...S, N.Y., Oct. 30 Consumers Union,nonprofit publis...t tests,showing that 4 out of 5 sunscreens that cl...articles appear,widespread in mineral-based sunscr...
...rns top honors for a four-star ease of use ...s!, OAK BROOK, Ill., Oct. 30 Learning Curve,Bran...tion (Nasdaq: RCRC ),( http://www.learningcurve.c... a four-star Ease of Use rating. The C360 was,the ...
... MD Who Signed Prop 8 Ballot Argument, SACRAMENTO... released a statement signed by more than 300 lead...t opposition to Prop 8 and concluding,that the phy...statement took issue with Dr. Anderson, who identi...
Other Medicine News:Health News:International Medical Corps Continues Delivering Emergency Relief Amid Violence in Democratic Republic of Congo 2Health News:Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens 2Health News:Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens 3Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 2Health News:Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform 3Health News:Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen 2Health News:The First Years True Fit C630 Convertible Car Seat Recieves Highest Given Rating From the National Highway Traffic Safety Administration 2Health News:NO on Prop 8 Campaign Releases Statement by 300 California Pediatricians 2
Excellence S+
Passive Plus DX
IsoFlex S
M 3.2 J Unipolar Atrial "J" Lead
Medicine Products: